Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Millennium Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$265M
Portfolio companies 13
Rounds per year 0.43
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Health Diagnostics
  • Finance

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Millennium Management:
Typical Co-investors
Millennium Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Millennium Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Agritech Capital North Carolina, United States, Wilmington
Canadian Trade Commissioner Service Canada, Ontario, Ottawa
Criabiz Ventures Brazil, São Paulo, Sorocaba
Dacheng Innovative Capital Management China, Guangdong, Tianjin
Elephant Capital England, London, United Kingdom
Guojin Dingxing Investment China, Shanghai
Henan Maisheng Medical Technology -
K2MediaLabs -
Media Ventures Cologne, Germany, Nordrhein-Westfalen
Pilot Group Florida, Sarasota, United States
Rongsheng Huitong Beijing, China, Pinggu
Sora Ventures China, Hong Kong, Hong Kong Island
Table Mountain Ventures New York, New York, United States
Tanant Capital -
TV Azteca -
U-Start Italy, Lombardy, Milan
Western Economic Diversification Canada Alberta, Canada, Edmonton
YSS Capital Central, Central Region, Singapore

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cardurion Pharmaceuticals

Biotechnology
Pharmaceutical
$260M16 Jul 2024 Boston, Massachusetts, United States

Metagenomi

Artificial Intelligence
Machine Learning
$175M25 Jan 2022 California, United States

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$81M23 Dec 2020 Boulder, Colorado, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Millennium Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 265M
Rounds per year 0.43
Peak activity year 2021
Lead investments 0
Follow on index 0.13
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cardurion Pharmaceuticals

Biotechnology
Pharmaceutical
$260M16 Jul 2024 Boston, Massachusetts, United States

Metagenomi

Artificial Intelligence
Machine Learning
$175M25 Jan 2022 California, United States

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$81M23 Dec 2020 Boulder, Colorado, United States
Crunchbase icon

Content report

The following text will be sent to our editors: